Navigation Links
Arena Pharmaceuticals Provides Corporate Update and Reviews Fourth Quarter and Full Year 2012 Financial Results
Date:3/4/2013

SAN DIEGO, March 4, 2013 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today provided a corporate update and reviewed financial results for the fourth quarter and full year ended December 31, 2012.

"2012 was a momentous year for Arena with the FDA approval of our first drug, BELVIQ," said Jack Lief, Arena's President and Chief Executive Officer. "It is a time of great pride, with BELVIQ representing the first of what we expect will be many novel treatments resulting from our validated research and development approach."

BELVIQ® (lorcaserin HCl) was approved on June 27, 2012, by the US Food and Drug Administration as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g. hypertension, dyslipidemia, type 2 diabetes). Once the US Drug Enforcement Administration, or DEA, finalizes the scheduling designation, BELVIQ will be available to eligible patients in the United States by prescription.

"We look forward to the US launch of BELVIQ, and the opportunity to make this important treatment option available to physicians and patients in other parts of the world," said Dominic P. Behan, Ph.D., Arena's Executive Vice President and Chief Scientific Officer. "We are also focused on advancing our pipeline of potential new treatments for unmet medical needs."

Recent Developments:BELVIQ® (lorcaserin HCl)

  • The DEA issued a Notice of Proposed Rulemaking proposing BELVIQ be placed in Schedule IV of the Controlled Substances Act. Once final, BELVIQ will be made available by prescription to eligible patients in the United States. BELVIQ will be manufactured by Arena
    '/>"/>

  • SOURCE Arena Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Arena Pharmaceuticals Announces First Quarter 2012 Financial Results and Recent Developments
    2. Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock
    3. Arena Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
    4. Aperture Health, Inc., Targeting the Strong Growth in the Long Term Disease Management arena
    5. Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs
    6. Arena Pharmaceuticals to Present at the Seventh Annual JMP Securities Healthcare Conference
    7. Arena Pharmaceuticals Files Marketing Authorization Application in Switzerland for Lorcaserin as a Treatment for Weight Control
    8. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Thursday, August 9
    9. Arena Pharmaceuticals Announces Second Quarter 2012 Financial Results and Recent Developments
    10. Arena Pharmaceuticals to Present at Upcoming Investor Conferences
    11. Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/2/2015)...  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ) ... and commercialization of a once-daily, oral therapy for the ... that Josh Blacher , Chief Financial Officer, will ... conference in Laguna Niguel, California ... Standard Time. A live webcast of the presentation will ...
    (Date:3/2/2015)...  SI-BONE, Inc., a medical device company that pioneered ... the sacroiliac (SI) joint with the iFuse Implant System ... have now been performed world wide utilizing more than ... iFuse procedure continues to grow and gain momentum with ... the United States and 17 countries ...
    (Date:3/2/2015)... N.J. and BETHESDA, Md. ... development-stage immunotherapy company focused on treating and preventing autoimmune ... 2-stage, anti-IL-15 monoclonal antibody (AMG 714) from Amgen (NASDAQ: ... exclusive license agreement, Celimmune has the rights to develop, ... excluding Japan . Concurrently, Amgen has ...
    Breaking Medicine Technology:Galmed Pharmaceuticals to Present at the 27th Annual ROTH Conference 2SI-BONE, Inc. Announces 15,000 iFuse Procedure Milestone 2SI-BONE, Inc. Announces 15,000 iFuse Procedure Milestone 3Celimmune Announces Anti-IL-15 Antibody Licensing and Option Agreements with Amgen 2Celimmune Announces Anti-IL-15 Antibody Licensing and Option Agreements with Amgen 3
    (Date:3/2/2015)... (PRWEB) March 02, 2015 Robins & ... In conjunction with Women in Construction Week (March 1-7, ... or NAWIC) and National Women’s History Month, Robins & ... positively affect the company and the construction industry as ... team, to the dozens of roles in between, each ...
    (Date:3/2/2015)... (PRWEB) March 02, 2015 The Workgroup ... authority on the use of health IT to create ... paper, “ICD-10 Testing for Small Providers.” The white paper ... a starting point for ICD-10 testing by focusing on ... to ensure compliance with the October 1, 2015 implementation ...
    (Date:3/2/2015)... This year, the National Multiple Sclerosis Society’s annual ... for people across the country to unite, raise awareness, ... live their best lives. MS Awareness Week is a special ... join the Society’s vision of a world free of MS. ... of the central nervous system, interrupts the flow of information ...
    (Date:3/2/2015)... Four Seasons Resort Maui at Wailea, the ... this year, having officially opened its doors on March 2, ... honoring over 70 employees who started on Day 1 and ... approximately 400 original employees. The celebration will be a ... , This Four Seasons flagship resort, the first resort ...
    (Date:3/2/2015)... 2015 What are the best practices ... references? When are interviews scheduled, how can physicians best ... training and practicing physicians who are looking for new ... more at the PracticeLink Physician Career Advancement Workshop and ... Fair is from 5:30 to 8:30 p.m. at the ...
    Breaking Medicine News(10 mins):Health News:Robins & Morton Recognizes Women In Construction 2Health News:WEDI Releases New White Paper on ICD-10 Testing for Small Providers 2Health News:Every Connection Counts During MS Awareness Week 2Health News:Every Connection Counts During MS Awareness Week 3Health News:Every Connection Counts During MS Awareness Week 4Health News:Celebrating Four Seasons Resort Maui’s 25th Anniversary 2Health News:PracticeLink to Host a Career Advancement Workshop and Job Fair in Houston 2
    ... proof cancer will spread to the healthy second ... -- Women diagnosed with breast cancer who have a ... breast removed as a preventive measure. , The rate ... than doubled from 1998 to 2003, according to a ...
    ... JOSE, Calif., Oct. 22 The start of the,patent ... ) against,three endovenous laser competitors, Diomed, AngioDynamics and Vascular,Solutions, ... of,October 29. The delay is due to a busy ... to identify potential new trial start dates. At,the conference, ...
    ... Dialysis Corporation,of America (Nasdaq: DCAI ) ... 2007 earnings after the close of the markets ... America owns and operates freestanding kidney,hemodialysis centers located ... and Virginia, and provides in-hospital,dialysis services on a ...
    ... to Act in Good Faith with Employees, Leads,District ... The American Federation,of Government Employees (AFGE), which represents ... Health System (NF/SGVHS), today,criticized the Department of Veterans ... with its employees by failing to honor the ...
    ... Oct. 22 AtriCure, Inc.,(Nasdaq: ATRC ), a ... cardiac surgical devices, will release,its financial results for the ... AtriCure will host a conference call at 10:00 ... quarter 2007 results. A live web cast of,the conference ...
    ... Cereal cuts cardiovascular risk, as do fruits, veggies, research ... rich in whole grains, fruits, vegetables and even a ... studies show. , In one study, regular consumption of ... for male American physicians. , Another study, this time ...
    Cached Medicine News:Health News:More Women Choosing 'Preventive' Double Mastectomy 2Health News:More Women Choosing 'Preventive' Double Mastectomy 3Health News:Delay in Start of VNUS Patent Litigation and Court Ruling on Summary Judgment Motion 2Health News:Dialysis Corporation of America Announces Third Quarter 2007 Earnings Release Date 2Health News:Mismanagement at North Florida/South Georgia Veterans Health System Results in Chronic Staff Shortages, Budget Issues 2Health News:AtriCure Announces Web Cast and Conference Call of Third Quarter 2007 Financial Results 2Health News:Whole Grains Do a Heart Good 2Health News:Whole Grains Do a Heart Good 3
    The Easy Wrap Apron is now available with an attached Thyroid Collar. The Thyroid Collar is held on with velcro so it adjusts to fully protect the neck. This Apron with Collar is available in 5mm lea...
    ... knee system is a long ... a clinically proven design. Available ... anatomically correct cruciate retaining configurations. ... ease of identification keeps the ...
    ... The Genesis II® Total Knee System will ... far more is possible with less - ... while fully addressing both clinical and cost ... these design goals, giving surgeons creative solutions ...
    Cementless hip system...
    Medicine Products: